Janvier Labs completed the acquisition of a majority stake in Firalis Molecular Precision for €27m.

Synopsis

Janvier Labs, a biomedical research company, completed the acquisition of a majority stake in Firalis Molecular Precision, a provider of advanced BioAnalytical Testing services, for €27m.

Principals

target

Firalis Molecular Precision

bidder

Janvier Labs

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

rothschild & co

HQ - Paris

financial advisors

target

3148

Deals

£ 1,643.43 B

Total Value